RETA | Reata Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: Irving, Texas, United States Trade prices Volume: 11.1M Market Cap: 1.11B Prev closed: 138.63 Open: 138.74 High: 144.68 Low: 131.76 52 week low: 76.34 52 week high: 186.82 Dividends: No Dividends Next ER: August 14, 2023
About the Company Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, Reata is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, ...
Earnings History Date EPS / Forecast Revenue / Forecast November 7, 2023 August 14, 2023 - / -1.25- / 15.43MMay 10, 2023 -1.81 / -2.41200K / 191.43KBeat! March 13, 2023 -2.33 / -2.32- / 491.43KNovember 8, 2022 -1.47 / -2.21540K / 1.03MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 7, 2023 166.42 166.5 167.09
166.05
1.6M 0.02% Aug 4, 2023 166.39 166.95 167.21
166.12
751K -0.46% Aug 3, 2023 167.16 166.21 167.59
165.86
1.3M 0.39% Aug 2, 2023 166.51 166.05 167.24
165.52
704K 0.25% Aug 1, 2023 166.1 165.51 167.1
165.32
1.3M 0.31% Jul 31, 2023 165.58 165.51 166.88
165.08
3.3M -0.96% Jul 28, 2023 167.19 164.69 167.24
164.25
12.3M 54.02% Jul 27, 2023 108.55 106.83 111.74
104.79
1.4M 2.32% Jul 26, 2023 106.09 106.25 107.71
104.5
641K -0.37% Jul 25, 2023 106.48 109.88 111.49
105.83
574K -2.91% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2002 Employees:123 News
Biogen agrees to buy Reata Pharmaceuticals in deal valued at $7.3B seekingalpha.com Jul 28, 2023 7:18 pm Reata Pharma Stock Skyrockets After Winning 'Coin-Flip' FDA Approval finance.yahoo.com Jul 28, 2023 6:36 pm Reata Pharma Stock Halted After Winning 'Coin-Flip' FDA Approval finance.yahoo.com Jul 28, 2023 6:03 pm
Pharma Stock Surges After FDA Approves Treatment finance.yahoo.com Jul 28, 2023 2:30 pm
Analysts Estimate Janux Therapeutics, Inc. (JANX) to Report a Decline in Earnings: What to Look Out for finance.yahoo.com Jul 28, 2023 10:01 am
Reata's (RETA) Skyclarys PAS Gets FDA Nod, Stock Rises 7% finance.yahoo.com Jul 28, 2023 9:18 am
Edited Transcript of RETA.OQ earnings conference call or presentation 8-Aug-22 12:30pm GMT finance.yahoo.com Jul 28, 2023 8:30 am
Reata Pharmaceuticals, Inc. (RETA) Stock Jumps 20.6%: Will It Continue to Soar? finance.yahoo.com Jul 28, 2023 8:05 am Biogen to buy Reata for $6.5 billion to bulk up rare disease portfolio finance.yahoo.com Jul 28, 2023 7:21 am
Why Reata Pharma Shares Are Skyrocketing Today finance.yahoo.com Jul 28, 2023 7:17 am
Reata Soars on Approval for Rare Disorder Drug. Its Pipeline Value Impresses Analysts. finance.yahoo.com Jul 28, 2023 7:14 am
Biogen to Acquire Reata Pharmaceuticals finance.yahoo.com Jul 28, 2023 7:05 am
Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreichs Ataxia finance.yahoo.com Jul 28, 2023 6:45 am
Reata Pharmaceuticals, Inc. Announces Third Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs finance.yahoo.com Jul 28, 2023 6:40 am
Reata Pharmaceuticals, Inc. Announces First Quarter 2023 Financial Results and Provides an Update on Operational Progress and Clinical Development Programs finance.yahoo.com Jul 28, 2023 6:40 am Reata Pharmaceuticals ticks higher amid takeover speculation seekingalpha.com Jul 27, 2023 9:50 pm
TipRanks Perfect 10 List: Analysts Pound the Table on These Top-Rated Stocks finance.yahoo.com Jul 23, 2023 5:24 am
3 Top Biotech Stocks Defying the Bear Market finance.yahoo.com Jul 13, 2023 7:45 am TD Cowen starts Reata at outperform, cites sales potential of ataxia drug seekingalpha.com Jul 7, 2023 12:51 am Reata Surges 12% Over Three Days; CEO Reflects On The Tricky Path To Launch A First-Ever Drug finance.yahoo.com Jun 29, 2023 4:10 pm This company doesn't provide a dividend.
Key Persons CFO : Jason Wilson Chief Medical Officer : Seemi Khan Talk about Reata Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 78 HOLD 22 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.